Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Creating a Formula for Precise, Effective Literature Searching

Posted on July 31st, 2017 by in Pharmacovigilance

Even those who are old enough to remember the days before the internet might find it hard to imagine living our lives now without access to digital information tools. People working in pharmacovigilance today may actually shudder at the thought of having to do their jobs without biomedical research solutions. Continue reading “Creating a Formula for Precise, Effective Literature Searching” »

Biosimilars Development & its Future

Posted on July 10th, 2017 by in Pharma R&D

The pharmaceutical industry had really been quite optimistic as of late regarding regulatory overhaul and getting rid of the ever-present ‘red tape’ within the regulatory body in the US, and the FDA had shown a very positive response towards getting biosimilars approved. Continue reading “Biosimilars Development & its Future” »

Crisis Prevention in Pharmacovigilance

Posted on October 12th, 2016 by in Pharmacovigilance

One of the challenging situations that Pharmacovigilance functions will have to manage one day or another is a pharmacovigilance crisis. Continue reading “Crisis Prevention in Pharmacovigilance” »

Biosimilars and Pharmacovigilance: What You Need to Know—and Do—Now

Posted on April 26th, 2016 by in Pharmacovigilance

A few weeks ago, the US FDA approved Inflectra (infliximab-dyyb), a biosimilar to infliximab. This is the second US biosimilar approval, suggesting others may soon be on the way—good news for companies with biosimilars pending approval and in development. Continue reading “Biosimilars and Pharmacovigilance: What You Need to Know—and Do—Now” »

  1. 1
  2. 2